Abstract
Preterm neonates are at risk to acquire infections. In addition to the high mortality associated with sepsis, these patients are at risk for long-term disabilities, particularly neurodevelopment impairment. Several interventions have been evaluated to reduce rates of infections in neonates but have not proven efficacy. Lactoferrin (LF), a milk glycoprotein with anti-inflammatory, immunomodulatory and anti-microbial properties, has the potential to prevent infections in young children. We performed a review of current and ongoing clinical trials of LF for prevention of neonatal sepsis, and found eleven registered clinical trials that include more than 6,000 subjects. Few of these trials have finished; despite their small sample size, the preliminary results show a trend towards a positive protective effect of LF on neonatal infections. Larger trials are underway to confirm the findings of these initial studies. This information will help to define LF’s role in clinical settings and, if proven effective, would profoundly affect the treatment of low birth weight neonates as a cost-effective intervention worldwide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ammons MC, Copie V (2013) Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 29:443–455
Artym J, Zimecki M, Kruzel ML (2004) Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. Int Immunopharmacol 4:1149–1157
Baker HM, Baker EN (2012) A structural perspective on lactoferrin function. Biochem Cell Biol 90:320–328
Camacho-Gonzalez A, Spearman PW, Stoll BJ (2013) Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin N Am 60:367–389
Edde L, Hipolito RB, Hwang FF, Headon DR, Shalwitz RA, Sherman MP (2001) Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 281:1140–1150
Embleton ND, Berrington JE, McGuire W, Stewart CJ, Cummings SP (2013) Lactoferrin: antimicrobial activity and therapeutic potential. Semin Fetal Neonatal 2013:143–149
Lee WJ, Farmer JL, Hilty M, Kim YB (1998) The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun 66:1421–1426
Legrand D (2012) Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol 90:252–268
Leitch EC, Willcox MD (1999) Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 48:867–871
Lingappan K, Arunachalam A, Pammi M (2013) Lactoferrin and the newborn: current perspectives. Expert Rev Anti Infect Ther 11:695–707
Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE et al (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151–2161
Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H et al (2009) Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA J Am Med Assoc 302:1421–1428
Manzoni P, Stolfi I, Messner H, Cattani S, Laforgia N, Romeo MG et al (2012) Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 129:116–123
Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK et al (2001) Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun 69:1469–1476
Ochoa TJ, Cleary TG (2009) Effect of lactoferrin on enteric pathogens. Biochimie 91:30–34
Ochoa TJ, Pezo A, Cruz K, Chea-Woo E, Cleary TG (2012) Clinical studies of lactoferrin in children. Biochem Cell Biol 90:457–467
Orsi N (2004) The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17:189–196
Shane AL, Stoll BJ (2013) Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 30:131–142
Shane AL, Stoll BJ (2014) Neonatal sepsis: progress towards improved outcomes. J Infect 68:S24–S32
Sharma S, Kumar P, Betzel C, Singh TP (2001) Structure and function of proteins involved in milk allergies. J Chromatogr B Biomed Sci Appl 756:183–187
Sheffield CL, Crippen TL, Poole TL, Beier RC (2012) Destruction of single-species biofilms of Escherichia coli or Klebsiella pneumoniae subsp. pneumoniae by dextranase, lactoferrin, and lysozyme. Int Microbiol Off J Span Soc Microbiol 15:185–189
Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552–555
Sun XL, Baker HM, Shewry SC, Jameson GB, Baker EN (1999) Structure of recombinant human lactoferrin expressed in Aspergillus awamori. Acta Crystallogr D Biol Crystallogr 55:403–407
Thaver D, Zaidi AK (2009) Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 28:S3–S9
Venkatesh MP, Rong L (2008) Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative Staphylococci and Candida albicans causing neonatal sepsis. J Med Microbiol 57:1113–1121
Vogel HJ (2012) Lactoferrin, a bird’s eye view. Biochem Cell Biol 90:233–244
Watson D, O’Connell Motherway M, Schoterman MH, van Neerven RJ, Nauta A, van Sinderen D (2013) Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol 114:1132–1146
Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br J Exp Pathol 70:697–704
Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA (2005) Hospital-acquired neonatal infections in developing countries. Lancet 365:1175–1188
Zhang GH, Mann DM, Tsai CM (1999) Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun 67:1353–1358
Acknowledgments
This study was supported by the Public Health Service award (R01-HD067694) from the National Institute of Child Health and Human Development (NICHD), USA.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Turin, C.G., Zea-Vera, A., Pezo, A. et al. Lactoferrin for prevention of neonatal sepsis. Biometals 27, 1007–1016 (2014). https://doi.org/10.1007/s10534-014-9754-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-014-9754-3